TABLE 1.

Over-presented pathways in relation with SLCO4A1 expression.

Database	Pathways	Size	NES	NOM p-val	FDR q-val
Enriched pathways in cell lines with higher SLCO4A1
BIOCARTA	TALL1	13	2.06	0	0.006
	CD40	14	2.02	0	0.011
	NFKB	20	1.97	0	0.015
	TNFR2	16	1.93	0	0.015
	KERATINOCYTE	45	1.94	0	0.018
	HIVNEF	53	1.82	0	0.046
	TID	18	1.83	0	0.047
	RELA	14	1.92	0.002	0.017
	CDMAC	16	1.89	0.002	0.024
	IL1R	30	1.79	0.002	0.052
	41BB	15	1.84	0.004	0.052
	LAIR	15	1.73	0.004	0.068
	DEATH	29	1.76	0.004	0.062
	CSK	16	1.83	0.006	0.071
	PPARA	48	1.83	0.008	0.047
	IL7	16	1.77	0.008	0.059
KEGG	NOD like receptor signaling	54	1.97	0	0.034
	Adipocytokine signaling	60	1.84	0	0.072
	Cell adhesion molecules CAMS	118	1.73	0.002	0.107
	Leishmania infection	64	1.89	0.002	0.069
	Apoptosis	81	1.82	0.002	0.072
	TOLL like receptor signaling	79	1.85	0.002	0.084
	Nature killer cell mediated cytotoxicity	98	1.72	0.006	0.104
Enriched pathways in cell lines with lower SLCO4A1
BIOCARTA	ETC	10	1.93	0	0.032

Size, the numbers of genes included in the pathway; NES, normalized enrichment score; NOM p-val, normalized p-value; FDR q-val, False discovery rate q-value.